在小型双臂临床试验中用于随机化目的的数学编程工具:使用真实数据的案例研究
Alan R Vazquez1, Weng-Kee Wong2
1School of Engineering and Sciences, Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico.
Pharmaceutical statistics
|April 13, 2024
概括
现代临床试验随机化使用适应性方法. 数学编程增强了自适应性随机化,平衡受试者共变量和组大小,在小型试验中表现优于传统方法.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 统计方法 统计方法
背景情况:
- 适应性随机化在现代临床试验中是标准的,使用累积的数据来分配受试者.
- 数学编程提供先进的自适应方法,以平衡试验组的大小和共变量分布.
- 现有的共变量适应性随机化方法具有局限性,特别是在小型试验中.
研究的目的:
- 审查和比较基于数学编程的自适应随机化方法与常见的共变量自适应方法.
- 引入一种新的能量距离测量方法,以评估基于联合共变量分布的组差异.
- 为了证明使用这种新指标的数学编程方法的优越性.
主要方法:
- 对适应性随机化技术的审查,重点是数学编程方法.
- 引入能量距离度量来量化群体之间的共变量分布差异.
- 数字实验比较数学编程方法与标准的共变量适应方法.
主要成果:
- 数学编程方法在平衡主题共变量方面具有显著的优势.
- 拟议的能源距离测量方法提供了比边际分布比较更全面的对集团平衡的评估.
- 数值实验证实了在新能源距离度量下数学编程的有效性.
结论:
- 基于数学编程的自适应随机化在临床试验中提供了对组平衡的优越控制.
- 能量距离测量是评估随机化方法性能的一个有价值的工具.
- 这些先进的方法在小型临床试验中尤为有益,提高了研究有效性.
相关概念视频
Randomized Experiments
6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Statistical Software for Data Analysis and Clinical Trials
546
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
546
Comparing the Survival Analysis of Two or More Groups
179
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
179
Hazard Ratio
116
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
116
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K


